Myocardial infarction vaccine? Evidence supporting the influenza vaccine for secondary prevention

This publication has 13 references indexed in Scilit:

• Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome
  European Heart Journal, 2011
• Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice
  Atherosclerosis, 2010
• Use of Oseltamivir After Influenza Infection Is Associated With Reduced Incidence of Recurrent Adverse Cardiovascular Outcomes Among Military Health System Beneficiaries With Prior Cardiovascular Diseases
  Circulation: Cardiovascular Quality and Outcomes, 2009
• Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study
  European Heart Journal, 2008
• Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects
  European Heart Journal, 2007
• Influenza Vaccination as Secondary Prevention for Cardiovascular Disease
  Circulation, 2006
• Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
  New England Journal of Medicine, 2004
• Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) StudyOne-year follow-up
  Published by Oxford University Press (OUP) ,2004
• Azithromycin for the Secondary Prevention of Coronary Heart Disease Events
  JAMA, 2003
• Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease
  Circulation, 2000